(19)
(11) EP 1 585 500 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.07.2017 Bulletin 2017/30

(45) Mention of the grant of the patent:
10.05.2017 Bulletin 2017/19

(21) Application number: 03800247.3

(22) Date of filing: 22.12.2003
(51) International Patent Classification (IPC): 
A61K 9/14(2006.01)
A61K 9/16(2006.01)
A61K 9/50(2006.01)
(86) International application number:
PCT/US2003/041391
(87) International publication number:
WO 2004/058223 (15.07.2004 Gazette 2004/29)

(54)

COATED PARTICLES FOR SUSTAINED-RELEASE PHARMACEUTICAL ADMINISTRATION

BESCHICHTETE PARTIKEL FÜR ARZNEIMITTELVERABREICHUNG MIT VERZÖGERTER FREISETZUNG

PARTICULES ENROBEES DESTINEES A L'ADMINISTRATION PROLONGEE D'INGREDIENTS PHARMACEUTIQUES


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 20.12.2002 US 435163 P
20.12.2002 US 435416 P
20.12.2002 US 435445 P
20.12.2002 US 435415 P
20.12.2002 US 435448 P
20.12.2002 US 435449 P
20.12.2002 US 435447 P
20.12.2002 US 435506 P
20.12.2002 US 435507 P
20.12.2002 US 435496 P
20.12.2002 US 435075 P
20.12.2002 US 435423 P
20.12.2002 US 435336 P
20.12.2002 US 435630 P
20.12.2002 US 435372 P
20.12.2002 US 435106 P
20.12.2002 US 435388 P
20.12.2002 US 435632 P
20.12.2002 US 435557 P
20.12.2002 US 435558 P
20.12.2002 US 435132 P
20.12.2002 US 435497 P
20.12.2002 US 435494 P
20.12.2002 US 435508 P
20.12.2002 US 435501 P
20.12.2002 US 435565 P
20.12.2002 US 435038 P
20.12.2002 US 435037 P
20.12.2002 US 435162 P
20.12.2002 US 435338 P
20.12.2002 US 435509 P
20.12.2002 US 435495 P
20.12.2002 US 435505 P
28.02.2003 US 450722 P
14.03.2003 US 454997 P

(43) Date of publication of application:
19.10.2005 Bulletin 2005/42

(73) Proprietor: Auritec Pharmaceuticals
Santa Monica, CA 90404 (US)

(72) Inventor:
  • SMITH, Thomas J.
    Pasadena, CA 91103 (US)

(74) Representative: Leonard, Thomas Charles et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)


(56) References cited: : 
GB-A- 2 241 889
US-A- 4 623 588
US-A- 3 867 519
US-A- 5 271 946
   
  • SUBHAGA C S ET AL: "EVALUATION OF AN ALIPHATIC POLYURETHANE AS A MICROSPHERE MATRIX FORSUSTAINED THEOPHYLLINE DELIVERY", JOURNAL OF MICROENCAPSULATION, TAYLOR AND FRANCIS, BASINGSTOKE, GB, vol. 12, no. 6, 1 November 1995 (1995-11-01), pages 617-625, XP000534681, ISSN: 0265-2048
  • Maria A Frohoff-Hü ET AL: "Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydroxypropyl methylcellulose as coating material for diffusion pellets I. Drug release rates from coated pellets", International Journal of Pharmaceutics, 1 January 1999 (1999-01-01), pages 69-82, XP055261187, Retrieved from the Internet: URL:http://ac.els-cdn.com/S037851739800327 5/1-s2.0-S0378517398003275-main.pdf?_tid=2 35edae0-f595-11e5-832a-00000aab0f02&acdnat =1459245840_055b716e3eb1a319c2af5d55acd2aa 4b
  • OZTURK A G ET AL: "Mechanism of release from pellets coated with an ethylcellulose-based film", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 14, no. 3, 1 December 1990 (1990-12-01), pages 203-213, XP025551792, ISSN: 0168-3659, DOI: 10.1016/0168-3659(90)90160-U [retrieved on 1990-12-01]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).